Olema Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.51

+0.07 (+0.74%)

As of Jun 21, 10:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +76.8% upside

Low Target $15.48

Average Target $16.81

High Target $21.94

Current Price $9.51

Current
$9.51

Target
$16.81

$15.48 $16.81 avg $21.94

Scenario Analysis

Bear Case

$15.48

62.8%

Low target

Base Case

$16.81

+76.8%

Avg target

Bull Case

$21.94

+130.7%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$36.26

-73.8% from high

52-Week Low

$3.90

+143.8% from low

Target vs 52W High

$16.81

-53.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%